IU Ventures — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
Qumulex builds QxControl, a browser-based platform that unifies video management and access control for commercial physical security, with cloud, on-premises, or hybrid deployment options.
Cloud ComputingCybersecurityIoTSaaSFishers, US
Tom Buckley(Founder)inJerome Fath(Director)Elizabeth Ball(Executive Officer, Director)Harry Johnson(Director)Scot Swenberg(Director)David Underwood(Executive Officer, Director)
Co-investorsElevate Ventures
Vascugen develops an induced-pluripotent stem cell (iPSC)-derived vasculogenic cell therapy intended to form new blood vessels and restore microvascular circulation in oxygen-starved tissues.
BiotechHealthtechLongevityMedical DevicesMadison, US
Marvin Yoder(Director)Mervin C. Yoder(Scientific Founder)Carter Cliff(Executive Officer, Director)Tom Novak(Director)Jeffrey Kennedy(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.